Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000518
Filing Date
2024-11-08
Accepted
2024-11-08 16:20:38
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6680
  Complete submission text file 0001610717-24-000518.txt   8096
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Cislini Jeff (Reporting) CIK: 0001969082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 241440919